Studies showed that functional EPO receptor signaling was critical for the tumor-promoting growth effects of EPO through in vitro and in vivo experiments, indicating that EPOR expression was positively correlated with the expression of the mitochondrial marker VDAC1 in human NSCLC patient biopsies. Here, EPO is linked to neoplasm.